We are live on ! Find out more
PMEF

Point72 Middle East FZE Portfolio holdings

AUM $3.38B
1-Year Est. Return 14.09%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+14.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.6B
AUM Growth
+$670M
Cap. Flow
+$559M
Cap. Flow %
15.51%
Top 10 Hldgs %
16.11%
Holding
2,193
New
624
Increased
517
Reduced
333
Closed
712

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$124M
2
CI icon
Cigna
CI
+$26.3M
3
LOW icon
Lowe's Companies
LOW
+$26M
4
V icon
Visa
V
+$24.5M
5
UNH icon
UnitedHealth
UNH
+$23.8M

Sector Composition

Rank Sector Weight
1 Technology 8.68%
2 Healthcare 7.32%
3 Consumer Discretionary 7.26%
4 Financials 6.68%
5 Industrials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWSC
2151
DELISTED
PowerSchool Holdings, Inc.
PWSC
-6,687
Closed -$133K
GTHX
2152
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-3,471
Closed -$9.3K
SILK
2153
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-16,018
Closed -$627K
BIG
2154
DELISTED
Big Lots, Inc.
BIG
-14,071
Closed -$154K
MORF
2155
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-4,225
Closed -$159K
ETRN
2156
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-13,923
Closed -$80.5K
OSG
2157
DELISTED
Overseas Shipholding Group Inc.
OSG
-12,824
Closed -$50K
GETR
2158
DELISTED
Getaround, Inc.
GETR
-18,121
Closed -$5.16K
PXD
2159
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
-19,100
Closed -$3.9M
NGM
2160
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-5,441
Closed -$22.2K
CPE
2161
DELISTED
Callon Petroleum Company
CPE
-10,553
Closed -$353K
CBAY
2162
DELISTED
Cymabay Therapeutics
CBAY
-19,618
Closed -$171K
AYX
2163
DELISTED
Alteryx Inc
AYX
-1,859
Closed -$109K
SPLK
2164
DELISTED
Splunk Inc
SPLK
-23,364
Closed -$2.24M
ICVX
2165
DELISTED
Icosavax, Inc. Common Stock
ICVX
-2,002
Closed -$11.6K
THRX
2166
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
-16
Closed -$142
NVTA
2167
DELISTED
Invitae Corporation
NVTA
-5,578
Closed -$7.53K
TSP
2168
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
-38,275
Closed -$56.3K
ESMT
2169
DELISTED
EngageSmart, Inc.
ESMT
-5,843
Closed -$112K
ARAV
2170
DELISTED
Aravive, Inc. Common Stock
ARAV
-2,601
Closed -$5.2K
LTHM
2171
DELISTED
Livent Corporation
LTHM
-19,786
Closed -$430K
SGEN
2172
DELISTED
Seagen Inc. Common Stock
SGEN
-11,071
Closed -$2.24M
PACW
2173
DELISTED
PacWest Bancorp
PACW
-17,057
Closed -$166K
HT
2174
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
-11,101
Closed -$74.6K
VMW
2175
DELISTED
VMware, Inc
VMW
-30,642
Closed -$3.83M

Similar funds

Point72 Middle East FZE's Q2 2023 Portfolio in Review

As of Q2 2023, Point72 Middle East FZE held 2,193 positions worth $3.6B, up 23% from $2.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Point72 Middle East FZE deployed $559M of net new capital in Q2 2023, opening 624 new positions and adding to 517 existing holdings. Its largest new stake was AbbVie: 129,855 shares worth $17.5M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $21.6M trimmed.

  • Point72 Middle East FZE's largest Q2 2023 buy was AbbVie: 129,855 shares worth $17.5M.
  • Point72 Middle East FZE added most to iShares Russell 2000 ETF in Q2 2023, an estimated $50.1M increase.
  • Point72 Middle East FZE's biggest Q2 2023 reduction was Honeywell, cutting an estimated $21.6M.
  • Point72 Middle East FZE fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $124M.
  • Point72 Middle East FZE's ten largest holdings make up 16% of its $3.6B portfolio in Q2 2023.
  • Point72 Middle East FZE opened 624 new positions and closed 712 in Q2 2023.
  • Point72 Middle East FZE's portfolio value rose 23% quarter-over-quarter to $3.6B.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.